Cargando…

USP44 Promoter Methylation in Plasma Cell-Free DNA in Prostate Cancer

SIMPLE SUMMARY: Liquid biopsy provides real-time monitoring of tumor evolution and response to therapy through analysis of circulating tumor cells (CTCs) and plasma-circulating tumor DNA (ctDNA). USP44 is a member of family proteins deubiquitinases, and plays an important role in cell growth; howeve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Londra, Dora, Mastoraki, Sophia, Bournakis, Evangelos, Zavridou, Martha, Thanos, Anastasios, Rampias, Theodoros, Lianidou, Evi S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467003/ https://www.ncbi.nlm.nih.gov/pubmed/34572834 http://dx.doi.org/10.3390/cancers13184607

Ejemplares similares

PIM-1 Is Overexpressed at a High Frequency in Circulating Tumor Cells from Metastatic Castration-Resistant Prostate Cancer Patients
por: Markou, Athina, et al.
Publicado: (2020)

DNA Methylation Analysis in Plasma Cell-Free DNA and Paired CTCs of NSCLC Patients before and after Osimertinib Treatment
por: Ntzifa, Aliki, et al.
Publicado: (2021)

Prognostic Significance of Gene Expression and DNA Methylation Markers in Circulating Tumor Cells and Paired Plasma Derived Exosomes in Metastatic Castration Resistant Prostate Cancer
por: Zavridou, Martha, et al.
Publicado: (2021)

Direct comparison of size-dependent versus EpCAM-dependent CTC enrichment at the gene expression and DNA methylation level in head and neck squamous cell carcinoma
por: Zavridou, Martha, et al.
Publicado: (2020)

Prognostic Significance of SLFN11 Methylation in Plasma Cell-Free DNA in Advanced High-Grade Serous Ovarian Cancer
por: Tserpeli, Victoria, et al.
Publicado: (2021)

Comprehensive liquid biopsy analysis as a tool for the early detection of minimal residual disease in breast cancer
por: Stergiopoulou, Dimitra, et al.
Publicado: (2023)

miRNA-21 as a novel therapeutic target in lung cancer
por: Markou, Athina, et al.
Publicado: (2016)

KMT2C promoter methylation in plasma‐circulating tumor DNA is a prognostic biomarker in non‐small cell lung cancer
por: Mastoraki, Sofia, et al.
Publicado: (2020)

Prognostic Role of RASSF1A, SOX17 and Wif-1 Promoter Methylation Status in Cell-Free DNA of Advanced Gastric Cancer Patients
por: Karamitrousis, Evangelos I., et al.
Publicado: (2021)

Prognostic Significance of TWIST1, CD24, CD44, and ALDH1 Transcript Quantification in EpCAM-Positive Circulating Tumor Cells from Early Stage Breast Cancer Patients
por: Strati, Areti, et al.
Publicado: (2019)

USP44 Promotes the Tumorigenesis of Prostate Cancer Cells through EZH2 Protein Stabilization
por: Park, Jae Min, et al.
Publicado: (2019)

Direct comparison study of DNA methylation markers in EpCAM-positive circulating tumour cells, corresponding circulating tumour DNA, and paired primary tumours in breast cancer
por: Chimonidou, Maria, et al.
Publicado: (2017)

A closed-tube methylation-sensitive high resolution melting assay (MS-HRMA) for the semi-quantitative determination of CST6 promoter methylation in clinical samples
por: Dimitrakopoulos, Lampros, et al.
Publicado: (2012)

RASSF1A promoter methylation in high-grade serous ovarian cancer: A direct comparison study in primary tumors, adjacent morphologically tumor cell-free tissues and paired circulating tumor DNA
por: Giannopoulou, Lydia, et al.
Publicado: (2017)

Detection and relevance of epigenetic markers on ctDNA: recent advances and future outlook
por: Lianidou, Evi
Publicado: (2021)

DNA methylation analysis of tumor suppressor genes in liquid biopsy components of early stage NSCLC: a promising tool for early detection
por: Markou, Α., et al.
Publicado: (2022)

Oropharyngeal cancer: the dawn of the RNA era in precision medicine
por: Rampias, Theodoros
Publicado: (2020)

Exploring the Eco-Evolutionary Dynamics of Tumor Subclones
por: Rampias, Theodoros
Publicado: (2020)

Metabolism-Related Gene Expression in Circulating Tumor Cells from Patients with Early Stage Non-Small Cell Lung Cancer
por: Zafeiriadou, A., et al.
Publicado: (2022)

Preoperative Mutational Analysis of Circulating Tumor Cells (CTCs) and Plasma-cfDNA Provides Complementary Information for Early Prediction of Relapse: A Pilot Study in Early-Stage Non-Small Cell Lung Cancer
por: Markou, A. N., et al.
Publicado: (2023)

What's new on circulating tumor cells? A meeting report
por: Lianidou, Evi S, et al.
Publicado: (2010)

Overexpression of Ubiquitin Specific Protease 44 (USP44) Induces Chromosomal Instability and Is Frequently Observed in Human T-Cell Leukemia
por: Zhang, Ying, et al.
Publicado: (2011)

Methylation-sensitive high-resolution melting analysis of the USP44 promoter can detect early-stage hepatocellular carcinoma in blood samples
por: Kim, Si-Cho, et al.
Publicado: (2022)

Detection of EGFR Mutations in Plasma cfDNA and Paired CTCs of NSCLC Patients before and after Osimertinib Therapy Using Crystal Digital PCR
por: Ntzifa, Aliki, et al.
Publicado: (2021)

Mitonuclear Interactions in the Maintenance of Mitochondrial Integrity
por: Karakaidos, Panagiotis, et al.
Publicado: (2020)

TP53 mutational landscape of metastatic head and neck cancer reveals patterns of mutation selection
por: Klinakis, Apostolos, et al.
Publicado: (2020)

HDAC Inhibitors: Dissecting Mechanisms of Action to Counter Tumor Heterogeneity
por: Karagiannis, Dimitris, et al.
Publicado: (2021)

Biological and Clinical Significance of Adaptive Evolution of Coronaviruses
por: Beloukas, Apostolos, et al.
Publicado: (2021)

Cancer Evolution in Precision Medicine Era
por: Karagiannis, Dimitris, et al.
Publicado: (2022)

USP44 Stabilizes DDB2 to Facilitate Nucleotide Excision Repair and Prevent Tumors
por: Zhang, Ying, et al.
Publicado: (2021)

Insight into the physiological and pathological roles of USP44, a potential tumor target (Review)
por: Lou, Yuming, et al.
Publicado: (2022)

Detection of ESR1 Mutations in Primary Tumors and Plasma Cell-Free DNA in High-Grade Serous Ovarian Carcinoma Patients
por: Stergiopoulou, Dimitra, et al.
Publicado: (2022)

Advances in circulating tumor cells (ACTC): from basic research to clinical practice
por: Lianidou, Evi S, et al.
Publicado: (2013)

The deubiquitinase USP44 promotes Treg function during inflammation by preventing FOXP3 degradation
por: Yang, Jing, et al.
Publicado: (2020)

USP44 positively regulates innate immune response to DNA viruses through deubiquitinating MITA
por: Zhang, Hong-Yan, et al.
Publicado: (2020)

PIK3CA hotspot mutations in circulating tumor cells and paired circulating tumor DNA in breast cancer: a direct comparison study
por: Tzanikou, Eleni, et al.
Publicado: (2019)

The archaeal transamidosome for RNA-dependent glutamine biosynthesis
por: Rampias, Theodoros, et al.
Publicado: (2010)

Resolving DNA Damage: Epigenetic Regulation of DNA Repair
por: Karakaidos, Panagiotis, et al.
Publicado: (2020)

N-terminal domain mutations of the spike protein are structurally implicated in epitope recognition in emerging SARS-CoV-2 strains
por: Klinakis, Apostolos, et al.
Publicado: (2021)

Deubiquitination in prostate cancer progression: role of USP22
por: Nag, Nivedita, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ravf9ei693phd73ndjta9jtmoj